Accéder au contenu
Merck

Prognostic significance of genetic alterations detected by high-density single nucleotide polymorphism array in gastric cancer.

Cancer science (2010-03-25)
Motohisa Tada, Fumihiko Kanai, Yasuo Tanaka, Masashi Sanada, Yasuhito Nannya, Keisuke Tateishi, Miki Ohta, Yoshinari Asaoka, Motoko Seto, Fumio Imazeki, Haruhiko Yoshida, Seishi Ogawa, Osamu Yokosuka, Masao Omata
RÉSUMÉ

We sought to identify genomic changes that could be useful for clinical application, focusing on chromosomal instability and using a high-density single nucleotide polymorphism (SNP) array. We analyzed 34 gastric cancer cell lines for areas of DNA that exhibited copy number changes using the Affymetrix GeneChip Human Mapping 50 K Arrays. The results obtained with the cell lines were verified in 42 gastric cancer tissues using genomic PCR, quantitative real-time PCR, and loss of heterozygosity (LOH) analyses. Twenty-six local homozygous deletion regions, including 13 novel loci, and 31 recurrent high-grade gain regions, encompassing 14 novel loci, were found in the gastric cancer cell lines. Among the genes detected for high-grade gain in the cell lines, MYC, PAK1, and ITGB4BP showed copy number gain in more than 40% of gastric cancer tissues. LOH of AB051467, PTPRD, A2BP1, and C20orf133 was detected in more than 35% of gastric cancer tissues. The number of LOH was significantly greater in tumors with lymph node metastasis. In the early stage, the prognosis of patients with LOH of less than two genes was significantly better than that of those with LOH of two genes or more. Using high-density SNP arrays, we identified several novel and minute genomic alterations. LOH of four genes could be useful for prediction of lymph node metastasis and prognosis in early stage gastric cancers.